July 6, 2017
Precision for Medicine Expands Its Global Footprint for Oncology Development ServicesRead more...
April 13, 2017
Precision's David Parker Discusses CDx Development Relationships with Clinical OmicsDiscover more...
April 7, 2017
Pat Devitt Risse in Life Science Leader: Bet On Biomarkers for Better OutcomesGet the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of concept to drug approval.
Precision Oncology’s Messerschmidt on Protocol Development in PharmaVOICE
Precision Oncology’s Dr. Gerald Messerschimdt discusses clinical protocol develo... Discover more »
Briefing: Best Practices for the Expedited Start-Up of Oncology Trials
Precision subject matter expert, Tandy Tipps, highlights how oncology sites can... Discover more »
Pat Devitt Risse in Life Science Leader: Bet On Biomarkers for Better Outcomes
Perspective: Convergence of CLIA and FDA Requirements: A Rationale Shift in the Regulatory Paradigm
The laboratory developed test (LDT) has proven to be a flexible, quick, lower-in... Discover more »
6 Critical Factors for Achieving Approval of Oncology Drugs
In this high-stakes, high-velocity environment of oncology drug development and... Discover more »